97 results
Search Results
2. CAR T therapies in multiple myeloma: unleashing the future
3. STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient
4. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway
5. Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors.
6. IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway
7. Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer
8. CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1
9. Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis
10. Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform
11. Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model
12. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
13. Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo
14. CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status
15. CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
16. ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma
17. H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2
18. Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsy
19. Divergent transcriptomic signatures from putative mesenchymal stimuli in glioblastoma cells
20. Emerging role of RNA modification and long noncoding RNA interaction in cancer
21. Roles of circRNAs in the progression of colorectal cancer: novel strategies for detection and therapy
22. Utilizing nullomers in cell-free RNA for early cancer detection
23. Genetic mutation patterns among glioblastoma patients in the Taiwanese population – insights from a single institution retrospective study
24. Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancer
25. Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice
26. Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT
27. Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy
28. Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway
29. The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC
30. miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression
31. The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation
32. Cancer-associated fibroblast exosomes promote prostate cancer metastasis through miR-500a-3p/FBXW7/HSF1 axis under hypoxic microenvironment
33. Single-cell atlas reveals the immunosuppressive microenvironment and Treg cells landscapes in recurrent Glioblastoma
34. Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines
35. Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer
36. Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer
37. Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis
38. Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: A real-world study
39. SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer
40. Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway
41. Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers
42. BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors
43. Schwann cell derived pleiotrophin stimulates fibroblast for proliferation and excessive collagen deposition in plexiform neurofibroma
44. Sleeping Beauty transposon mutagenesis in mouse intestinal organoids identifies genes involved in tumor progression and metastasis
45. Modification of the tumor microenvironment enhances immunity with plasmid gene therapy
46. Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells
47. LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
48. Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration
49. GRIN2A mutation is a novel indicator of stratifying beneficiaries of immune checkpoint inhibitors in multiple cancers
50. METTL3-mediated RanGAP1 promotes colorectal cancer progression through the MAPK pathway by recruiting YTHDF1
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.